ChristopherBrowningHurtMDFIDSA
Infectious Disease • Chapel Hill, NCHIV/AIDS Medicine, STD Medicine
Associate Professor of Medicine, Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine
Dr. Hurt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UNC Infectious Diseases Clinic
100 Eastowne Drive
Chapel Hill, NC 27514Phone+1 984-974-7198Fax+1 984-974-4587- Is this information wrong?
Education & Training
University of North Carolina HospitalsFellowship, Infectious Disease, 2006 - 2009
Brown UniversityResidency, Internal Medicine, 2003 - 2006
University of Florida College of MedicineClass of 2003
Certifications & Licensure
NC State Medical License 2006 - 2024
RI State Medical License 2005 - 2006- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Respiratory Virus Hospitalization Study (FLU 003 Plus) Start of enrollment: 2009 Aug 01
- Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
- The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas: A Multi-site Cross-Sectional Study, 2018-2020.Umedjon Ibragimov, Melvin D Livingston, April M Young, Judith Feinberg, P Todd Korthuis, Wajiha Z Akhtar, Wiley D Jenkins, Heidi M Crane, Ryan P Westergaard, Robin Nan...> ;AIDS and Behavior. 2024 Jan 1
- 4 citationsFactors associated with perceived ease of access to syringes in Appalachian North Carolina.Delesha M Carpenter, William A Zule, Caitlin M Hennessy, Donna M Evon, Christopher B Hurt, Bayla Ostrach> ;The Journal of Rural Health. 2023 Jan 1
- 12 citationsEfficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled...Gary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo-Chen Chan, Katharine J Bar, Ruanne V Barnabas, Dan H Barouch, Myron S C...> ;The Lancet. Infectious Diseases. 2022 Oct 1
- Join now to see all
Journal Articles
- The Effects of Hepatitis C Infection and Treatment on All-Cause Mortality Among People Living with Human Immunodeficiency VirusAdaora A Adimora, Christopher B Hurt, Chloe L Thio, Phyllis C Tien, Clinical Infectious Diseases
Professional Memberships
- Member
- Member
- American Sexually Transmitted Diseases Association - ASTDAMember
- HIV Medicine Association - HIVMAMember
Hospital Affiliations
University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
